Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion

Clinical Endocrinology

Volumn 62, Issue 5, 2005, Pages 597-602

  Tzanela, M ^a   Zianni, D ^a   Stylianidou, Ch ^a   Karavitaki, N ^a   Tsagarakis, S ^a,b   Thalassinos, N C ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b Athens Polyclinic ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; PYRIDOSTIGMINE;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; BODY MASS; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; STEROID RELEASE; SUBCLINICAL AUTONOMOUS GLUCOCORTICOID HYPERSECRETION;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; ANALYSIS OF VARIANCE; CHOLINESTERASE INHIBITORS; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYDROCORTISONE; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PYRIDOSTIGMINE BROMIDE; STATISTICS, NONPARAMETRIC;

EID: 18444369627     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02266.x     Document Type: Article

References (23)

1. Devoe, V.J., Miller, W.L., Conte, F.A., Kaplan, S.L., Grumbach, M.M., Rosenthal, S.M., Wilson, C.B. & Gitelman, S.E. (1997) Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 82, 3196-3202.
2. Burguera, B., Muruais, C., Penalva, A., Dieguez, C. & Casanueva, F.F. (1990) Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology, 51, 51-58.
3. Smals, A.E., Pieters, G.F., Smals, A.G., Benraad, T.J. & Kloppenborg, P.W. (1986) Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adrenocortical adenoma. Clinical Endocrinology, 24, 401-407.
4. Tzanela, M., Karavitaki, N., Stylianidou, C., Tsagarakis, S. & Thalassinos, N.C. (2004) Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clinical Endocrinology, 60, 309-314.
5. Bengtsson, B.-A., Abstract, R., Bennmarker, H., Monson, J.P., Feldt-Rasmussen, U., Hernberg-Stahl, E., Westberg, B., Wilton, P. & Wuster, C. (1999) The effects of treatment and the individual responsiveness to Growth Hormone (GH) replacement therapy in 665 GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84, 3929-3935.
6. Monson, J.P. (2003) Long-term experience with GH replacement therapy: efficacy and safety. European Journal of Endocrinology, 143, S9-S14.
7. Murray, R., Adams, J. & Shalet, S.M. (2004) Adults with partial growth hormone deficiency have an adverse body composition. Journal of Clinical Endocrinology and Metabolism, 89, 1586-1591.
8. Rossi, R., Tauchmanova, L., Luciano, A., Di Martino, M., Battista, C., Del Viscovo, L., Nuzzo, V. & Lombardi, G. (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism, 85, 1440-1448.
9. Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y. & Bornstein, S.R. (2004) The clinically inapparent adrenal mass: Update in diagnosis and management. Endocrine Reviews, 25, 309-340.
10. Hadjidakis, D., Tsagarakis, S., Roboti, C., Sfakianakis, M., Iconomidou, V., Raptis, S.A. & Thalassinos, N. (2003) Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clinical Endocrinology, 58, 72-77.
11. Terzolo, M., Pia, A., Ali, A. et al. (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism, 87, 998-1003.
12. Tsagarakis, S., Kokkoris, P., Roboti, C., Malagari, C., Kaskarelis, J., Vlassopoulou, V., Alevizaki, C. & Thalassinos, N. (1998a) The low dose-dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology, 48, 627-633.
13. Liddle, G.W. (1960) Tests of pituitary-adrenal suppressability in the diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 20, 1539-1560.
14. Growth Hormone Research Society. (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 379-381.
15. Aimaretti, G., Baffoni, C., DiVito, L., Bellone, S., Grotolli, S., Maccario, M., Arvat, E., Camanni, F. & Ghigo, E. (2000) Comparisons among old and new provocative tests of GH secretion in 178 normal adults. European Journal of Endocrinology, 142, 347-352.
16. Hoeck, H.C., Vestergaard, P., Jakobsen, P.E., Falhof, J. & Laurberg, P.A. (1999) Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults. Growth Hormone IGF Research, 9, 18-24.
17. Hoeck, H.C., Vestergaard, P., Jakobsen, P.E., Falhof, J. & Laurberg, P.A. (2000) Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues. Journal of Clinical Endocrinology and Metabolism, 85, 1467-1472.
18. Grumbach, M.M., Biller, B.M.K., Braunstein, G.D. et al. (2003) Management of the clinically inapparent adrenal mass ('incidentalomas'). Annals of Internal Medicine, 138, 424-429.
19. Valli, N., Catargi, B., Ronci, N. et al. (2001) Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. European Journal of Endocrinology, 144, 401-408.
20. Tsagarakis, S., Roboti, C., Kokkoris, P., Vasiliou, V., Alevizaki, C. & Thalassinos, N.C. (1998b) Elevated postdexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clinical Endocrinology, 49, 165-171.
21. Williams, T., Berelowitz, M., Joffe, S.N., Thorner, M.O., Rivier, J., Vale, W. & Frohman, L.A. (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. New England Journal of Medicine, 311, 1403-1407.
22. Bonert, V.S., Elashoff, J.D., Barnett, P. & Melmed, S. (2004) Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. Journal of Clinical Endocrinology and Metabolism, 89, 3397-3401.
23. Terzolo, M., Bossoni, S., Ali, A. et al. (2000) Growth hormone responses to GH-releasing hormone alone or combined with Arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. Journal of Clinical Endocrinology and Metabolism, 85, 1310-1315.